Mow Jonathan P 4
4 · PhaseBio Pharmaceuticals Inc · Filed May 21, 2019
Insider Transaction Report
Form 4
Mow Jonathan P
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2019-05-17$2.27/sh+19,913$45,203→ 71,112 total - Exercise/Conversion
Common Stock
2019-05-20$1.24/sh+19,131$23,722→ 90,243 total - Exercise/Conversion
Employee stock option (right to buy)
2019-05-17−19,913→ 0 totalExercise: $2.27From: 2016-12-03Exp: 2022-12-21→ Common Stock (19,913 underlying) - Exercise/Conversion
Employee stock option (right to buy)
2019-05-20−19,131→ 0 totalExercise: $1.24From: 2018-03-14Exp: 2024-03-31→ Common Stock (19,131 underlying)